Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis

NCT01516515 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: Vehicle gel
DRUG: SR-T100 with 2.3% of SM

Sponsor

G&E Herbal Biotechnology Co., LTD